Differential (Click to cross reference) adverse drug reaction andexanet anticoagulant, complications of anticoagulant, reversal of anticoagulant, treatment anticoagulation effect apixaban atrial fibrillation atrial fibrillation, nonvalvular bedridden cerebrovascular accident cerebrovascular accident, cardiac disease causing cerebrovascular accident, prevention of complications coumarin dabigatran edoxaban efficacy enoxaparin factor Xa inhibitor gastrointestinal bleeding hemorrhagic diathesis hemostatic therapy intracerebral hemorrhage non-vitamin K antagonist oral anticoagulants non-vitamin K antagonist oral anticoagulants, coagulation test partial thromboplastin time peri-procedural prothrombin time prothrombin time, prolonged rivaroxaban safety thrombin inhibitor transient ischemic attack treatment of neurologic disorder

Showing articles 0 to 6 of 6 Coagulation Test Interpretation in a Patient Taking Direct Oral Anticoagulant Therapy JAMA 320:1485-1486, Sholzberg, M. & Xu, Y., 2018 Which Oral Anticoagulation for Atrial Fibrillation? JAMA 315:2117-2118, The Medical Letter, 2016 Outcomes with Edoxaban Versus Warfarin in Patients with Previous Cerebrovascular Events Stroke 47:2075-2082, Rost, N.S.,et al, 2016 Andexanet Alfa for the Reversal of Factor Xa Inhibitor Activity NEJM 373:2413-2424,2471, Siegal, D.M.,et al, 2015 Cerebrovascular Events in 21 105 Patients with Atrial Fibrillation Randomized to Edoxaban Versus Warfarin Stroke 45:2372-2378, Giugliano, R.P.,et al, 2014 Edoxaban Versus Warfarin in Patients with Atrial Fibrillation NEJM 369:2093-2104, Giugliano, R.P.,et al, 2013 Showing articles 0 to 6 of 6